# Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial

> **NCT00169832** · PHASE3 · COMPLETED · sponsor: **Laval University** · enrollment: 193 (actual)

## Conditions studied

- Diabetes
- Coronary Artery Bypass Grafting

## Interventions

- **DRUG:** Rosiglitazone or placebo

## Key facts

- **NCT ID:** NCT00169832
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2008-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169832, "Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00169832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*